In this exposé, we dive into the secretive pharmaceutical strategy known as 'evergreening.' While the law suggests that drug patents should expire to allow for cheap generic competition, multi-billion dollar corporations have found a way to keep their monopolies alive indefinitely. By making tiny, non-therapeutic changes to existing formulas, they create a 'patent thicket' that blocks affordable medicine from reaching the market. This video explores how taxpayer-funded research is being held hostage by corporate legal teams, driving up your insurance premiums and pharmacy costs. Learn how the system designed to foster innovation has been repurposed into a tool for permanent wealth extraction from the public to the elite.
